Search

Your search keyword '"Fredriksson, Martin"' showing total 606 results

Search Constraints

Start Over You searched for: Author "Fredriksson, Martin" Remove constraint Author: "Fredriksson, Martin"
606 results on '"Fredriksson, Martin"'

Search Results

52. Dilemmas of Protection : Decolonising the Regulation of Genetic resources and Cultural Heritage

53. Pirate Utopia Revisited

55. Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58

59. Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58

60. 303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial

61. 1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

62. Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study

63. Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study

69. The Political Economy of Intellectual Property Rights: the Paradox of Article 27 Exemplified in Ghana

71. Between Intellectual and Cultural Property : Myths of Authorship and Common Heritage in the Protection of Traditional Cultural Expression

74. Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58.

75. 244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

76. DAPAGLIFLOZIN AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND PRIOR MYOCARDIAL INFARCTION: A SUB-ANALYSIS FROM DECLARE TIMI-58 TRIAL

77. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

78. Authors, Inventors and Entrepreneurs: Intellectual Property and Actors of Extraction

79. Where does the Mine End

81. Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58.

82. Bellamy’s Rage and Beer’s Conscience: Pirate Methodologies and the Contemporary University

83. Commons, Piracy and Property: Crisis, Conflict and Resistance

85. From biopiracy to bioprospecting : Negotiating the Limits of Propertization

86. GC-bro med limträstomme : Dimensionering av Nya Älvbron med hjälp av datorbaserat dimensioneringsprogram

90. Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study.

96. Extracting the Commons

97. Property, place and piracy

99. Piracy: Leakages from Modernity

Catalog

Books, media, physical & digital resources